INTRODUCTION
Obesity is a well-known risk factor of many diseases including coronary heart disease, diabetes, metabolic syndrome etc. It has been shown that there was a direct relation between the markers of oxidative stress, susceptibility of LDL to oxidation and general obesity [Dandona et al., 2001; Olusi, 2002 Recently it has been shown that obesity and being overweight is strongly associated with elevated LDL oxidation and chronic low grade infl ammation in humans [Wang et al., 2010] . Several factors such as leptin, IL-1, TNF-a, IL-6 and resistin are overproduced by adipocytes as well as macrophages in adipose tissue [Das, 2002] . On the other hand, plasma levels of adiponectin, as an insulin-sensitizer, are down-regulated in obese patients [Hung et al., 2008] . Many studies have demonstrated that a moderate red wine consumption decreased the risk and mortality from coronary heart disease [Gaziano et al., 1993 ; Kerry & Abbey, 1997; Kondo et al., 1994; Natella et al., 2001; Iriti & Vitalini, 2012] . Previously, our data provided evidence for the acute antioxidant effect of red wine, especially the organic types, but there were no statistically signifi cant effects on the LDL-oxidation in humans. From our data, it can be concluded that the long--term consumption of red wine might have more potent antioxidant activity rather than a single dose, possibly due to the storage ability of fl avonoids in body tissues as suggested by Luzzi & Maiani [1999] . We hypothesed that wine fl avonoids might be stored in adipose tissue and exert their anti-oxidant / anti-infl ammatory effect in overweight subjects who have adipocytes where there was no accumulation of macrophages.
We investigated the effects of long-term (1 month) wine consumption on the antioxidant-oxidant system and infl ammatory markers in both healthy and overweight subjects at risk of atherosclerosis and metabolic syndrome due to insulin resistance and adipocyte mass. We aimed to study whether red wine has an anti-infl ammatory and antioxidative effect in overweight subjects.
SUBJECTS AND METHODS

Subjects
Ten overweight (6 men, 4 women) and 14 age-matched (7 men, 7 women) healthy subjects were enrolled in this study.
At the baseline, detailed clinical history of ethanol intake, smoking and dietary habits were collected by a structured All the subjects included in the study followed an isocaloric diet, which was designed according to their personal preferences. Subjects with regular alcohol consumption were excluded. All participants were asked to drink 200 mL/day of wine before dinner for 4 weeks. Since our previous data showed that Merlot and Cabernet sauvignon type wines showed a great antioxidant activity (AOA) and inhibitory effect against LDL-oxidation as well as high total phenol levels, all participants drank Cabernet Sauvignon type wine in this study.
All participants were informed about the study and treatment protocol and gave written informed consent. The study was approved by the local Ethics Committee (protocol no:06-1/31) and conducted in accordance with the 1975 Helsinki Declaration, as amended in 1983).
Methods
Venous blood samples were taken at baseline and on the 30 th day of wine consumption. Following centrifugation at 3500 rpm at 4°C for 15 min, plasma or serum was collected and stored at −80°C for a few weeks, until they were assayed. Serum concentrations of glucose, total cholesterol, HDL-cholesterol, triglycerides were measured in a chemical autoanalyzer with routine methods. LDL-cholesterol levels were calculated according to Friedman's formula. [Yildirim et al., 2005] The solution of 0.1 mmol/L DPPH (1,1-diphenyl-2-pikrylhydrazin) was rapidly mixed well with serum sample (1/100; v/v). The decline in absorbance was recorded at 550 nm against ethanol blank over a period of 20 min in 5-min intervals in microplate reader. Trolox was used as standard. [Pulido et al., 2000] Mixing solution (10:1:1, v/v/v) of acetate buffer (10 mmol/L, pH=3.6), TPTZ (2,4,6 tripyridyl-s-triazine) (10 nol/LM) and FeCl 3 (20 mmol/L) were added into serum sample and stored at room temperature for 30 min. Readings were done at 620 nm in a microplate reader.
TAO -Total antioxidant activity
FRAP -Ferric Reducing Antioxidant Power
Total phenols [Singleton & Rossi, 1965; Stratil et al., 2006] Total phenolic content was determined by Folin-Ciocalteu method in the following modifi cation: 0.200 mL of sample and 1.0 mL of Folin-Ciocalteu reagent diluted with water (1/10) were mixed. After 2 min; 0.8 mL of saturated sodium carbonate was added. After mixing on a shaker and heating at 50 o C for 5 min, the reading was performed at 760 nm in a spectrophotometer against blank. The results were expressed as gallic acid equivalents (GAE) using calibration curve against gallic acid (Merck) standard (100 mg/L).
Serum paraoxonase and arylesterase activities
Serum paraoxonase and arylesterase activities were measured as described previously [Mackness et al., 1991] . Briefl y, paraoxon (5.5 mmol/L) and arylesterase were used as the substrates and the rates of their hydrolysis were determined in 100 mmol/L Tris/HCl buffer containing 2 mmol/L CaCl 2 at pH 8.0. P-nitrophenol in various concentrations (between 0.5 and 10.0 nmol/mL) that is product of paraoxonase reaction, was used as standard. Arylesterase activity was calculated using extinction coeffi cient.
In vitro serum oxidation [Stupans et al., 2002] Following dilution of serum with phosphate buffered saline (1/200: v/v), in vitro oxidation of serum was induced by incubating with 5 mmol/L CuSO 4 at 30 o C for 120 min. Before (basal diene) and after (stimulated diene) incubation period, the absorbance was measured at 234 nm with LKB spectrophotometer and the calculations were performed using the extinction coeffi cient of 29,500 L/mol-cm.
Preparation of hemolysates
After separation of plasma, the packed erythrocytes were washed two times with 9 g/L NaCl solution and hemolysed with ice-cold water (1/5, v/v). The hemoglobin values were measured with the Drabkin's method.
Erythrocyte SOD (eSOD) activities
The eSOD activities were measured based on the inhibition of epinephrine autoxidation by SOD at 480 nm, with a Schimadzu spectrophotometer [Sozmen et al., 2001] . The assay was calibrated by using purifi ed SOD and one unit of enzyme was defi ned as the amount of enzyme, which inhibits 50% of autoxidation of epinephrine.
Erythrocyte catalase (eCAT) activities
The eCAT activities were determined as described by Sozmen et al. [2001] in which the degradation of hydrogen peroxide is recorded spectrophotometrically at 240 nm. One unit of CAT was defi ned as the amount of enzyme, which decomposes 1 μmol H 2 O 2 /min under specifi c conditions.
Enzyme linked immunosorbent assays (ELISA) were used for the determination of plasma levels of high sensitive-C-reactive protein (hsCRP) (DRG Diagnostics, EIA 3954,USA), interleukin-6 (IL-6) (Biosource, KHC0061, USA), tumor necrosis factor alpha (TNF-) (Biosource, Cat.: KHC3011, USA), interleukin-10 (IL-10) (Biosource, Cat.: KHC0101, USA) and adiponectine (LINCO Research, Cat.: EZHADP-61K, USA).
Statistical analysis
Statistical analysis was performed using SPSS 13.0 computer package. All descriptive data were expressed as mean ± SD. Comparisons of the baseline characteristics between the 2 groups were performed by Mann-Whitney-U Test and Student's T-test. The effect of wine in each group was assessed by Paired Wilcoxon Signed Ranks Test; p-values < 0.05 were considered as statistically signifi cant.
RESULTS
The b aseline characteristics and the serum lipid levels of subjects are summarized in Table 1 . As expected, BMI and weight of overweight subjects were higher (p<0.001) than these of the healthy controls. Total cholesterol (p<0.05), triglyceride (p<0.001), LDL-cholesterol (p<0.05) levels of overweight subjects were higher than these of the healthy subjects. There were no signifi cant differences in HDL-cholesterol levels between two groups. Following wine consumption glucose levels signifi cantly (p<0.05, Wilcoxon Signed Ranks Test) decreased in overweight participants, while lipid parameters did not show any change.
As it has been shown in Table 1 , there were no statistically signifi cant differences (Mann-Whitney-U test) in any of the parameters that show oxidant-antioxidant status between the groups at the beginning of the study. Although FRAP levels (p=0.064) of controls following wine consumption were higher than the baseline levels, these differences were not statistically signifi cant. Paraoxonase activities signifi cantly increased upon wine consumption in healthy controls (p<0.016). Arylesterase (p=0.047) of overweight subjects on 30 th day were higher than their baseline levels. FRAP (p=0.059) and phenol levels (p=0.08) also increased but not statistically signifi cant. While eSOD activity (p=0.08) was slightly decreasing, eCAT activity and eTBARS levels did not show any change in overweight subjects with wine consumption.
When the data were evaluated regarding to the group (healthy and overweight) ( Figure 1) ; basal and copper stimulated diene levels on the 30 th day of wine consumption were found as lower than the baseline levels in controls (p=0.035 and p=0.011, respectively). As it can be seen from Figure 1 , basal diene levels signifi cantly and stimulated diene levels insignifi cantly decreased on the 30 th day of wine consumption regarding to basal levels in overweight subjects (p=0.047, p=0.074, respectively).
CRP values of overweight subjects were higher than these of the healthy subjects (Table 2) but wine had no effect on CRP values both in healthy and overweight subjects. There was no change in TNF-, IL-6 and IL-10 levels following wine consumption in both groups. Plasma levels of adiponectin, as an insulin-sensitizer was lower, but not signifi cantly, in overweight patients compared to controls and wine consumption led to an increase in adiponectin levels of overweight subjects. . Phenolic compounds present in red wine cause an increase in serum total antioxidant capacity [Whitehead et al., 1995] , and thereby inhibit low-density lipoprotein (LDL) oxidation [Frankel et al., 1993] . We investigated possible antioxidant and anti-infl ammatory effect of red wine consumption in overweight subjects under the risk of atherosclerosis and metabolic syndrome due to insulin resistance and adipocyte mass.
Our data showed that moderate red wine consumption prevented LDL oxidation in both healthy and overweight subjects. The basal and copper-stimulated LDL diene levels of overweight subjects were not signifi cantly higher than those of the healthy subjects, and wine consumption signifi cantly decreased the basal and stimulated diene levels in healthy and overweight subjects (Figure 1 ). Several possible contributors to oxidative stress in obesity were reviewed by Vincent & Taylor [2006] . These factors comprise the hyperglycemia, lower intake of antioxidants, increased muscle activity to carry excessive weight, increased dietary fat intake, increased fat storage and excessive intracellular triglycerides and dyslipidemia, and chronic infl ammation [Vincent & Taylor, 2006] . Our study group (overweight but not obese) was subjected to oxidative stress due to high glucose, triglyceride and LDL cholesterol levels. Although there are a number of studies suggesting the antioxidant effects of red wine on LDL oxidation, the data obtained from in vivo studies were confl icting [Frankel et al., 1993; DeRijke et al., 1996; Nigdikar et al., 1998; Sarandol et al., 2003; Egert et al., 2009] . Previously it has been shown that both organic and inorganic wines consumed in the short term had no effect on basal and Cu-stimulated LDL oxidation DeRijke et al., 1996] . On the other hand, Sarandol et al. [2003] found that moderate red wine consumption signifi cantly reduced susceptibility of apolipoprotein B-containing lipoproteins to in vitro copper mediated oxidation, however there were no signifi cant differences between the basal (without incubation) TBARS levels before and after red wine consumption. In accordance with current data, showed that LDL of volunteers had a reduced propensity for copper ion-induced lipid peroxidation in comparison to LDL obtained at the baseline.
The effects of red wine consumption on LDL oxidation could be related to an elevation in the total polyphenols content in the plasma as well as in the LDL particle Nigdikar et al., 1998 ] and this current data also supported this notion. Since FRAP levels of controls and overweight subjects following wine consumption were observed to be higher than their baseline levels, we proposed that the protective effects of wine against oxidative stress directly depends on the antioxidative effect of its phenolic compounds (phenolic acids and fl avonoids). The main polyphenolic groups (fl avon and fl avolols, catechins, proanthocyanidins, benzoic acids) that are found in wines are effi cient scavengers of free radicals and breakers of lipid peroxidative chain reactions [Teissedre & Landrault, 2000] . They exert their antioxidant activity by chelating transition metals such as iron and copper ions, which are involved in free radical generation [Sagin & Sozmen, 2004] .
It has been clearly shown that paraoxonase (PON1) prevents LDL from oxidation by removing oxidized phospholipids from LDL [Sozmen et al., 2008] . Paraoxonase activity increased with wine consumption in control subjects and arylesterase activity in overweight subjects. Van der Gaag et al. [2009] observed that the alcohol-induced increase in serum paraoxonase activity after 3 weeks of red wine consumption correlated strongly with the elevation in HDL-C and apo A-I concentration. Our hypothesis is that the elevation in paraoxonase activity might be due to a decrease in lipid peroxidation via phenolic components in wine. Although it has been shown that infl ammatory cytokines especially CRP produced by adipocytes in diabetic patients were closely related to depleted PON1 activity [Dullaart et al., 2009] , wine had no effect on the infl ammatory cytokines in this study. Therefore, we supposed that this increase in PON1 activity is likely to be depleted in oxidative stress. The main substrate for PON1 is lipid hydroperoxide and PON1 is reduced through oxidative inactivation during detoxifi cation of lipid hydroperoxides by its esterolytic activity [Rice-Evans et al., 1996] . It has been suggested that other antioxidant enzymes might prevent this inhibition of PON1 activity. These enzymes play an important role in all stages of atherosclerosis and elevation in oxidative stress might inhibit them [Sozmen et al., 2008] . The current in vivo study showed that the long term wine consumption had no effect on erythrocyte antioxidant enzymes, eSOD and catalase, both in healthy and overweight subjects.
Besides this well-known antioxidant activity, polyphenols also have anti-infl ammatory effects. In this study, we inves- tigated some infl ammatory markers in overweight subjects compared to healthy controls and a possible effect of red wine on these parameters. We determined that overweight subjects had higher CRP values than controls, which was in accordance with a study by Warnberg et al. [2006] who showed that CRP concentrations were signifi cantly associated with overweight and obesity in both females and males. They suggested that obesity and being overweight during adolescence were associated with a chronic low-grade infl ammatory response. The data related to the effects of red wine consumption on infl ammatory markers were also confl icting. While some authors found no change in infl ammatory markers (IL-6, CRP) following acute intake of red wine and beer [Tousoulis et al., 2008] , others reported depletion in serum IL-6 levels [Sacanella et al., 2007] and an amplifi cation of IL-10 and reduction of NF-kappaB [Natella et al., 2001 ] following acute red wine intake. Avogaro et al. [2003] observed that moderate red wine intake improved post-glucose free fatty acid profi les but did not modify the plasma concentrations of both TNF- and adiponectin concentrations. We observed no change in CRP, TNF-, IL-6 and IL-10 levels following long-term wine consumption compared to their baseline levels in this study. These discrepancies between the different studies probably resulted from the dose and administration period of wine.
Previously Matsushita et al. [2006] found that the adiponectin level was a more signifi cant predictor than TNF-, IL-6 or CRP for prevalent metabolic syndrome. Our observation supported this data, and the adiponectin level was lower in overweight subjects at high risk of metabolic syndrome than those of healthy controls. Hung et al. [2008] showed that plasma adiponectin concentrations were inversely associated with insulin resistance scores independent of obesity and higher circulating adiponectin concentrations were associated with a reduced prevalence of metabolic syndrome and that this relationship was independent of the level of obesity and infl ammatory markers. We determined that there was an increase in adiponectin levels following wine consumption in overweight subjects. Adiponectin is not only an insulin--sensitizer, but also represses the pro-infl ammatory effects of TNF-alpha on the vascular system and probably prevents the progression of atherosclerosis [Ouchi et al., 1999] . In accordance with our data, Imhof et al. [2009] showed that the adiponectin levels among women signifi cantly increased after consuming red wine and increased among men after ethanol solution and consuming beer.
There was a signifi cant correlation between the adiponectin level and PON1 arylesterase activity and a negative correlation between the adiponectin level and fasting glucose levels in this study. Our data is consistent with fi ndings of other studies Seres et al., 2010] that showed that adiponectin proved to be an independent factor of PON1 activity in both childhood and adult obesity.
CONCLUSIONS
In conclusion, chronic moderate wine consumption (in a dose of 200 mL/day for 4 weeks) decreased basal and stimulated serum oxidation, increased antioxidant activity (FRAP) and had no effect on infl ammatory cytokines (CRP, IL-6, IL-10 and TNF) in both healthy and overweight subjects. One of the important data of this study is a decline in glucose levels and elevation in adiponectin levels in overweight subjects after wine consumption. We suggest that moderate wine consumption might delay the onset of atherosclerosis and metabolic syndrome by increasing paraoxonase/ arylesterase activity and adiponectin levels, as well as preventing LDL oxidation.
Since we do not have measures of insulin resistance we cannot discuss about the possible relationship between oxidative stress, adiponectin and insulin resistance. The number of volunteers who accept to drink wine regularly for a month has limited to get signifi cant results. With the same reason we could not conduct a statistical analysis between men and women.
